About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Deputy Director Peterlin Announces Resignation | Main | FDA Makes Changes in Erythropoietin Labeling »

July 30, 2008

Comments

je suis personnelement tres interessé par cette nouvelle mollecule et ce nouveau traitement.Ma mère est actuellement atteinte de cette maladie.Si il y avait une possibilité de lui faire suivre la phase '3 'de test basée sur le volontaria ,elle serait d'accord.
Merci d'avance pou elle de vos réponses et de vos commentaires.

How does one become part of the phase three trial

I'm very interested in contact with Dr Wischik because my husband suffer a cognitive disease that grow very fast.
Please, answer ASAP. We can travel to any place of the word if you consider a mininimun possibility for him. I can provide all the history of my husband under your request

Dear Damien, Jill, and Ana:

We do not have any details regarding the enrollment in the upcoming clinical trials that TauRx is planning to launch. I would suggest starting by contacting TauRx directly. TauRx's website seems to still be in the early stages of development, but it should at least provide you with a place to start your search.

My family has also had the unfortunate situation of dealing with Alzheimer's disease. It is a particularly cruel disease, so hopefully this therapeutic represents a real step forward in treatment. Good luck in your efforts to enroll in the trial.

Where can I obtain Rember medication?
My wife is in the later stages of Alzheimers desease.

TauRx has not been given approval for phase 3 studies. It may be in 2009 or even 2010 if the FDA delays it.
Hopefully, it may be approved for phase 3 earlier in Europe by the EMEA. Best to place a google alert for it. Good luck!

Hello,
My name is jawad, my family has the ofortunate situation of dealing with Alzeimer disease too. Few days ago we heard about the new medication the "rember" and also about a trial in 2009 or 2010 if the FDA delays it. Our questions are 1) when the medication will be on the market if the FDA delays it 2)About the trial: How and when can we put our Family name on the list trial for participate on the next phase.

My mother is in the early stages of alzhimer's and would benefit from this new drug how can she go on the waiting list for stage three trial. Please respond if you can help.

The comments to this entry are closed.

January 2022

Sun Mon Tue Wed Thu Fri Sat
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31